Dastmalchi, F., Karachi, A., Khattri, R., Merritt, M. E., Mitchell, D., & Rahman, M. (2017). METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS. Neuro Oncol.
Citação norma ChicagoDastmalchi, Farhad, Aida Karachi, Ram Khattri, Matthew E. Merritt, Duane Mitchell, and Maryam Rahman. "METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS." Neuro Oncol 2017.
MLA引文Dastmalchi, Farhad, et al. "METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS." Neuro Oncol 2017.
警告:這些引文格式不一定是100%准確.